Jane Street Group LLC Has $1.61 Million Position in Fidelity Disruptive Medicine ETF (NASDAQ:FMED)

Jane Street Group LLC increased its holdings in shares of Fidelity Disruptive Medicine ETF (NASDAQ:FMEDFree Report) by 200.4% in the 3rd quarter, according to its most recent filing with the SEC. The fund owned 61,342 shares of the company’s stock after purchasing an additional 40,924 shares during the period. Jane Street Group LLC’s holdings in Fidelity Disruptive Medicine ETF were worth $1,613,000 at the end of the most recent reporting period.

Separately, Wealth Enhancement Advisory Services LLC increased its position in Fidelity Disruptive Medicine ETF by 3.7% in the 3rd quarter. Wealth Enhancement Advisory Services LLC now owns 539,827 shares of the company’s stock worth $14,192,000 after buying an additional 19,240 shares during the period.

Fidelity Disruptive Medicine ETF Stock Up 0.3 %

Shares of FMED stock opened at $25.23 on Friday. The stock has a 50 day moving average of $25.78 and a 200-day moving average of $25.34. The firm has a market cap of $52.98 million, a PE ratio of 35.73 and a beta of 0.94. Fidelity Disruptive Medicine ETF has a 12 month low of $23.32 and a 12 month high of $26.68.

Fidelity Disruptive Medicine ETF Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, December 24th. Shareholders of record on Friday, December 20th were issued a $0.112 dividend. The ex-dividend date was Friday, December 20th. This is an increase from Fidelity Disruptive Medicine ETF’s previous quarterly dividend of $0.00. This represents a $0.45 dividend on an annualized basis and a yield of 1.78%.

Fidelity Disruptive Medicine ETF Company Profile

(Free Report)

The Fidelity Disruptive Medicine ETF (FMED) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed fund that invests in companies involved in disruptive innovation in Health Care. The fund invests in securities of domestic and foreign issuers FMED was launched on Apr 16, 2020 and is managed by Fidelity.

See Also

Want to see what other hedge funds are holding FMED? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Fidelity Disruptive Medicine ETF (NASDAQ:FMEDFree Report).

Receive News & Ratings for Fidelity Disruptive Medicine ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fidelity Disruptive Medicine ETF and related companies with MarketBeat.com's FREE daily email newsletter.